Amneal [AMRX] vs Prestige Consumer [PBH] Detailed Stock Comparison

Amneal

NASDAQ
Loading...

Prestige Consumer

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Amneal wins in 10 metrics, Prestige Consumer wins in 9 metrics, with 0 ties. Amneal appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Amneal Prestige Consumer Better
P/E Ratio (TTM) 1,036.00 17.92 Prestige Consumer
Price-to-Book Ratio -29.23 2.07 Amneal
Debt-to-Equity Ratio -22.94 56.91 Amneal
PEG Ratio 4.14 16.12 Amneal
EV/EBITDA 9.32 12.51 Amneal
Profit Margin (TTM) 0.12% 18.86% Prestige Consumer
Operating Margin (TTM) 15.46% 34.03% Prestige Consumer
EBITDA Margin (TTM) 15.46% 34.03% Prestige Consumer
Return on Equity 106.73% 12.30% Amneal
Return on Assets (TTM) 6.85% 6.50% Amneal
Free Cash Flow (TTM) $220.11M $243.29M Prestige Consumer
1-Year Return 20.07% -9.76% Amneal
Price-to-Sales Ratio (TTM) 1.14 3.33 Amneal
Enterprise Value $5.83B $4.75B Amneal
EV/Revenue Ratio 2.04 4.17 Amneal
Gross Profit Margin (TTM) 39.51% 57.34% Prestige Consumer
Revenue per Share (TTM) $9 $23 Prestige Consumer
Earnings per Share (Diluted) $0.01 $4.29 Prestige Consumer
Beta (Stock Volatility) 1.18 0.43 Prestige Consumer
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Amneal vs Prestige Consumer Stock Performance Analysis

Loading Price Chart...

Amneal
Prestige Consumer
Amneal Stock Overview | Prestige Consumer Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Amneal-3.11%-1.06%4.04%23.53%38.49%32.60%
Prestige Consumer-2.85%-0.08%-4.88%-20.38%-24.52%-19.21%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Amneal20.07%425.00%99.81%-30.00%-30.00%-30.00%
Prestige Consumer-9.76%24.02%73.02%28.12%494.04%425.00%

News Based Sentiment: Amneal vs Prestige Consumer

Amneal

News based Sentiment: POSITIVE

Amneal Pharmaceuticals experienced a highly positive month, driven by strong stock performance, positive analyst revisions, strategic debt refinancing, and progress in its product pipeline. While insider selling warrants monitoring, the overall narrative points to a company on a solid growth trajectory.

View Amneal News Sentiment Analysis

Prestige Consumer

News based Sentiment: POSITIVE

The month saw a notable increase in institutional investment alongside the announcement of a firm date for the release of second quarter earnings. These events signal growing confidence in the company and provide a clear catalyst for investors, making it a moderately important month for Prestige Consumer Healthcare.

View Prestige Consumer News Sentiment Analysis

Performance & Financial Health Analysis: Amneal vs Prestige Consumer

MetricAMRXPBH
Market Information
Market Cap i$3.25B$3.79B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,708,420406,280
90 Day Avg. Volume i1,696,790411,937
Last Close$9.97$61.00
52 Week Range$6.68 - $10.68$60.78 - $90.04
% from 52W High-6.60%-32.25%
All-Time High$24.48 (Aug 20, 2018)$90.04 (Mar 10, 2025)
% from All-Time High-59.27%-32.25%
Growth Metrics
Quarterly Revenue Growth0.03%0.07%
Quarterly Earnings Growth2.74%0.01%
Financial Health
Profit Margin (TTM) i0.00%0.19%
Operating Margin (TTM) i0.15%0.34%
Return on Equity (TTM) i1.07%0.12%
Debt to Equity (MRQ) i-22.9456.91
Cash & Liquidity
Book Value per Share (MRQ)$-0.36$37.06
Cash per Share (MRQ)$0.24$1.98
Operating Cash Flow (TTM) i$351.08M$251.52M
Levered Free Cash Flow (TTM) i$333.75M$188.69M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Amneal vs Prestige Consumer

MetricAMRXPBH
Price Ratios
P/E Ratio (TTM) i1,036.0017.92
Forward P/E i14.5916.12
PEG Ratio i4.1416.12
Price to Sales (TTM) i1.143.33
Price to Book (MRQ) i-29.232.07
Market Capitalization
Market Capitalization i$3.25B$3.79B
Enterprise Value i$5.83B$4.75B
Enterprise Value Metrics
Enterprise to Revenue i2.044.17
Enterprise to EBITDA i9.3212.51
Risk & Other Metrics
Beta i1.180.43
Book Value per Share (MRQ) i$-0.36$37.06

Financial Statements Comparison: Amneal vs Prestige Consumer

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AMRXPBH
Revenue/Sales i$695.42M$296.52M
Cost of Goods Sold i$439.53M$126.51M
Gross Profit i$255.89M$170.01M
Research & Development i$41.81MN/A
Operating Income (EBIT) i$100.92M$100.89M
EBITDA i$161.60M$91.97M
Pre-Tax Income i$37.49M$73.96M
Income Tax i$12.87M$23.83M
Net Income (Profit) i$24.62M$50.13M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AMRXPBH
Cash & Equivalents i$59.19M$97.88M
Total Current Assets i$1.51B$448.33M
Total Current Liabilities i$1.08B$106.62M
Long-Term Debt i$2.24B$1.04B
Total Shareholders Equity i$-59.39M$1.83B
Retained Earnings i$-594.87M$1.56B
Property, Plant & Equipment i$522.75M$53.29M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AMRXPBH
Operating Cash Flow i$-11.03M$47.51M
Capital Expenditures i$-13.60M$-3.48M
Free Cash Flow i$-10.91M$58.37M
Debt Repayment i$-235.53M$-2.64M
Common Stock Repurchase iN/A$-11.31M

Short Interest & Institutional Ownership Analysis

MetricAMRXPBH
Shares Short i5.05M1.51M
Short Ratio i3.323.44
Short % of Float i0.03%0.04%
Average Daily Volume (10 Day) i1,708,420406,280
Average Daily Volume (90 Day) i1,696,790411,937
Shares Outstanding i309.88M49.51M
Float Shares i168.76M48.85M
% Held by Insiders i0.46%0.01%
% Held by Institutions i0.46%1.08%

Dividend Analysis & Yield Comparison: Amneal vs Prestige Consumer

MetricAMRXPBH
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A$0.00
Ex-Dividend DateN/AN/A